Skip to Content

Eaton Vance Worldwide Health Sci R ERHSX

Analyst rating as of
NAV / 1-Day Return
14.72  /  0.20 %
Total Assets
1.1 Bil
Adj. Expense Ratio
1.410%
Expense Ratio
1.410%
Fee Level
Average
Longest Manager Tenure
6.43 years
Category
Health
Investment Style
Large Growth
Min. Initial Investment
1,000
Status
Open
TTM Yield
0.00%
Turnover
27%

Morningstar’s Fund Analysis ERHSX

Will ERHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Satisfactory rather than superior overall.

Senior Analyst

Summary

|

Eaton Vance Worldwide Health Sciences is an acceptable but not an exceptional source of exposure to its target sector, and all its share classes retain their Morningstar Analyst Ratings of Neutral.

Unlock our full analysis with Morningstar Investor